Is progesterone receptor a favorable prognostic factor of radiation therapy for adenocarcinoma of the uterine cervix?
The present study suggested that PgR status was associated with prognosis after radiation therapy for adenocarcinoma of the uterine cervix.
We demonstrate that Plexin D1 is in general ubiquitously expressed in tumor but not normal vasculature, as well as in malignant cells in a wide range of human tissues. This expression profile highlights Plexin D1 as a potentially valuable therapeutic target in clinical solid tumors, enabling simultaneous targeting of different tumor compartments.